Solventum CorpSOLV

NYSEHealthcareSurgical & Medical Instruments & Apparatus
Price (close)
$88.59
Market cap
$15.1B
P/E
10.5x
Revenue (TTM)
$8.3B
Net income
$1.4B
Dividend yield
—
1-year total return
25.7%
Net margin
17.3%
Revenue growth
-0.9%
Debt / equity
1.06x

What Solventum Corp does.

Solventum Corporation ("Solventum," "we," "our," "us," or the "Company"), is a leading global healthcare company developing, manufacturing, and commercializing a broad portfolio of solutions that leverages deep material science, data science, and digital capabilities to address critical customer and patient needs. We constantly seek to enable the improvement of standards of care and move healthcare forward with innovation powered by insights, clinical intelligence, technology, and manufacturing expertise. Our 70+ year history of discovering and innovating advanced solutions has helped us solve our customers’ toughest challenges.

Our solutions are relied on every day within the global healthcare industry to deliver higher-quality patient care, more efficient processes and workflows, and improved standards of safety and accuracy. Additionally, our products and services are present along a patient’s journey through prevention, diagnosis, treatment, and recovery.

Our business possesses strong customer relationships, a broad, wide-ranging, and well-known portfolio of brands, differentiated technology, and manufacturing expertise. We serve a diverse customer base, ranging from multidisciplinary hospitals to local clinics/practices. Our long-tenured and collaborative customer relationships globally give us unique insights into their needs and preferences. These insights inform our innovation processes, drive stronger customer retention, and create multiple avenues for further customer engagement.

Revenue and profit, by fiscal year.

Fiscal year20212022202320242025
Revenue—$8.1B$8.2B$8.3B$8.3B
Net income—$1.3B$1.3B$479.0M$1.6B
Free cash flow—$1.4B$1.6B$805.0M-$10.0M

More on SOLV.

Figures from Solventum Corp's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.